Clinical Trials

60 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06810609 2026-01-27

InDuRanS

176 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07073365 2025-12-30

BOOST

70 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07264647 2025-12-04

Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)

30 enrolled

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT05882513 2025-12-02

Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer

36 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07177092 2025-09-16

SURGAN-TKI

118 enrolled

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT04062708 2025-07-08

CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

38 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06998719 2025-05-31

ACCESS

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06939127 2025-04-22

Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC

38 enrolled

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT01753414 2025-01-06

POSTILV

44 enrolled 20 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03217071 2024-10-23

Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer

12 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung

NCT05766800 2024-09-19

Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06282536 2024-02-28

Neoadjuvant Therapy With Iruplinalkib for Potentially Resectable ALK Positive NSCLC: A Single Arm, Exploratory Trial

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05891080 2023-06-06

Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial

124 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04875585 2022-08-24

INNWOP1

33 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01059188 2022-03-11

Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)

69 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04943029 2021-09-02

NEOSUN

Phase 2 Unknown

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04470076 2020-07-14

Neoafa

Phase 2 Unknown

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00003231 2019-05-15

Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer

40 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00924209 2018-11-30

A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer

Phase 2 Terminated

7 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT00281827 2017-12-28

Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer

Phase 2 Terminated

22 enrolled 11 charts

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00226577 2017-03-23

Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.

52 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00963807 2017-03-17

A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC

26 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT00406302 2014-04-29

Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)

41 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00003111 2013-07-25

Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

10 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00002642 2012-10-08

SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer

116 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01574729 2012-06-28

rAd-p53

Phase 2 Unknown

120 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00191308 2011-10-21

Molecular Profiling in Lung Cancer Patients

30 enrolled 11 charts